Accessibility Menu
NewGenIvf Group logo

NewGenIvf Group(NASDAQ) NIVFW

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-88%
5 YearN/A
1 Year-20%
1 Month+2%
$0.02
+0.00%
+0.00Today
NewGenIvf Group last closing stock price
MetricPriceDate
Last closeUSD 0.022026-08-28
NewGenIvf Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.022026-08-20
1 month+1.74%USD 0.022026-07-29
3 month-32.43%USD 0.032026-05-29
Year to date+2.94%USD 0.022025-12-23
1 year-20.45%USD 0.022025-08-22
3 year-36.36%USD 0.032023-08-28
Since inception-87.5%USD 0.142022-03-17

NewGenIvf Group Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$5.45M

Net Income (TTM)

$9.03M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Price

$0.02

Volume

2

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.01 - $0.09

Estimated Earnings Date

Sep 2, 2026

NIVFW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NewGenIvf Group

NewGenIvf Group Limited specializes in providing assisted reproductive technologies (ART) for individuals and couples seeking fertility solutions. The company operates across multiple countries, including Thailand, Cambodia, Hong Kong, and Kyrgyzstan, offering a comprehensive suite of fertility treatments.

Products and Services
  • In vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI)
  • Diagnostic services including hormonal blood tests and chromosome analysis
  • Surrogacy arrangements and ancillary care for surrogate mothers
Growth Outlook
  • Expansion into new markets is anticipated to drive revenue growth
  • Increasing demand for fertility treatments supports long-term business sustainability
  • Strategic partnerships may enhance service offerings and patient reach
Financial Highlights
  • Recent quarterly revenue of 1,424,554 reflects a positive trend
  • Gross profit margin improved to 36.8% in the latest quarter
  • Current ratio of 3.12 indicates strong short-term financial health
NewGenIvf Group Limited is positioned in a growing industry with increasing demand for fertility solutions. The company's diverse range of services, including advanced reproductive technologies and supportive care, caters to a broad audience. Recent financial performance shows promising revenue growth and improved profitability metrics, indicating a potential for future expansion. The strong current ratio suggests that the company is well-equipped to meet its short-term obligations, further enhancing its attractiveness to potential investors.
AI Generated • Aug 3, 2026

Industry

Healthcare Providers and Services

Headquarters

Bangkok, BM 10110, TH

NIVFW Financials

Key Financial Metrics (TTM)

Gross Margin

23.72%

Operating Margin

-276.57%

Net Income Margin

338.20%

Return on Equity

32.69%

Return on Capital

-34.06%

Return on Assets

27.98%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

2

Avg. Volume

6.29K

Financials (TTM)

Gross Profit

$1.83M

Operating Income

-$8.36M

EBITDA

$9.81M

Operating Cash Flow

-$6.73M

Capital Expenditure

-$2.82K

Free Cash Flow

-$6.74M

Cash & ST Invst.

$758.62K

Total Debt

$4.86M

NewGenIvf Group Performance Analysis

NewGenIvf Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-09-30N/A
Q42024-12-31-13.5%
Q32025-09-30N/A
Q42025-12-3111.1%
NewGenIvf Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-09-30N/A
Q42024-12-31-251.9%
Q32025-09-30N/A
Q42025-12-31-145.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.42M

-6.2%

Gross Profit

$524.03K

+166.2%

Gross Margin

36.79%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

87

N/A

Net Income

-$7.67M

-2385.0%

EBITDA

-$7.27M

-2099.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$758.62K

+1302.2%

Total Debt

$4.86M

+1362.6%

Accounts Receivable

$1.07M

+105.8%

Inventory

$335.36K

+165.6%

Long Term Debt

$4.37M

+3572.7%

Short Term Debt

$494.16K

+131.4%

Return on Assets

27.98%

N/A

Return on Invested Capital

-24.66%

N/A

Free Cash Flow

-$6.36M

-27903.3%

Operating Cash Flow

-$6.35M

-27890.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACONAclarion, Inc.
$2.35-2.08%
KZIAKazia Therapeutics Ltd ADR
$13.77+1.40%
CMNDClearmind Medicine Inc.
$1.94+10.23%
YDESYD Bio Limited Ordinary Shares
$3.71-22.71%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About NIVFW

What is the current price of NewGenIvf Group?

NewGenIvf Group is trading at $0.02 per share.

What is the 52-week range for NewGenIvf Group?

Over the past 52 weeks, NewGenIvf Group has traded between $0.01 and $0.09.

How much debt does NewGenIvf Group have?

NewGenIvf Group total debt is unavailable.

How much cash does NewGenIvf Group have on hand?

NewGenIvf Group does not have cash on hand data available.

What is NewGenIvf Group’s dividend yield?

NewGenIvf Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.